Beclin1 circulating levels and accelerated ageing markers in COPD

F. Schlemmer (Créteil Cedex, France)

Source: International Congress 2017 – Systemic and airway biomarkers
Session: Systemic and airway biomarkers
Session type: Thematic Poster
Number: 1018
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Schlemmer (Créteil Cedex, France). Beclin1 circulating levels and accelerated ageing markers in COPD. 1018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes?
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Leptin levels are associated with reduced lung function in men with COPD
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


DNA-estimated ageing markers are associated with COPD
Source: International Congress 2018 – Role of omics in population studies
Year: 2018

MMP-2 expression in lung periphery is related to COPD progression
Source: Eur Respir J 2006; 28: Suppl. 50, 550s
Year: 2006

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Characterisation of asthma subgroups associated with circulating YKL-40 levels
Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017
Year: 2017



Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Inflammation-sensitive plasma proteins are associated with increased incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 629s
Year: 2007

Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019

A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018



Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
Source: Eur Respir J 2015; 45: 1482-1485
Year: 2015


The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002

Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006